Roche Holdings Ltd Sponsored ADR (0TDF)
LSE 
Summary
0TDF Chart
Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline Updates
Recursion Pharmaceuticals NASDAQ: RXRX is using artificial intelligence to generate and analyze biological data in an effort to improve drug discovery, advance internal therapeutic programs and support collaborations with larger pharmaceutical companies, CFO and President of Recursion U.K. Ben Taylor said during a BofA Global Research virtual conference.
Roche Is Getting More Benefit Of The Doubt On Improving Execution
Roche Holding AG remains a respectable long-term hold, supported by a deep pipeline, strong execution, and robust financial resources. Q2 results showed 5% revenue growth and better-than-expected operating margin, validating management's focus on R&D efficiency and cost control. Key upcoming clinical readouts in oncology, immunology, and hematology could drive meaningful revenue shifts over the next 12–24 months.
Roche Holding AG (RHHBY) Q2 2026 Earnings Call Transcript
Roche Holding AG (RHHBY) Q2 2026 Earnings Call Transcript
Roche Holdings Ltd Sponsored ADR (0TDF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Roche Holdings Ltd Sponsored ADR ever had a stock split?
Roche Holdings Ltd Sponsored ADR Profile
| Pharmaceuticals Industry | Healthcare Sector | Thomas Schinecker CEO | LSE Exchange | 771195104 CUSIP |
| CH Country | 103,249 Employees | 13 Mar 2026 Last Dividend | 27 Feb 2014 Last Split | - IPO Date |
Overview
Roche Holding AG is a globally recognized healthcare company that combines its strengths in both pharmaceuticals and diagnostics. With a rich heritage dating back to 1896, the company has established a significant presence across various continents including Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. Roche is committed to improving health and well-being by providing innovative solutions and cutting-edge products in multiple therapeutic areas and diagnostics. The company's headquarters are strategically located in Basel, Switzerland, ensuring a pivotal role in the global healthcare sector.
Products and Services
Roche Holding AG offers a diverse portfolio of products and services across a broad spectrum of medical needs and diagnostic requirements. The company’s offerings can be categorized into pharmaceutical products and diagnostic solutions.
- Pharmaceutical Products: Roche is a leader in developing and marketing medicines for a wide range of diseases. Their therapeutic areas include:
- Anemia
- Blood and solid tumors
- Dermatology
- Hemophilia
- Inflammatory and autoimmune diseases
- Neurological disorders
- Ophthalmology
- Respiratory disorders
- Transplantation
- Diagnostic Solutions: In addition to pharmaceuticals, Roche provides a comprehensive range of diagnostic tools. The company's diagnostics division offers in vitro diagnostic tests for a variety of health conditions, including but not limited to:
- Cancer
- Diabetes
- Covid-19
- Hepatitis
- Human Papillomavirus (HPV)
Through its relentless pursuit of innovation and its expansive portfolio, Roche Holding AG is at the forefront of shaping the future of healthcare by addressing some of the most challenging medical needs and advancing global health.
